Cargando…
Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis.
A previous study has shown that there are high levels of an abnormally-fucosylated form of haptoglobin (FHp) in the blood of cancer patients (Thompson & Turner, 1987b). In this study, we investigated the expression of this substance in serial blood specimens from women with ovarian or breast can...
Autores principales: | Thompson, S., Cantwell, B. M., Cornell, C., Turner, G. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977512/ https://www.ncbi.nlm.nih.gov/pubmed/1892771 |
Ejemplares similares
-
Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.
por: Thompson, S., et al.
Publicado: (1987) -
Analysis of Serum Haptoglobin
Fucosylation in Hepatocellular
Carcinoma and Liver Cirrhosis of Different Etiologies
por: Zhu, Jianhui, et al.
Publicado: (2014) -
Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression
por: Choi, Hyewon, et al.
Publicado: (2023) -
Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios
por: Shang, Shuxin, et al.
Publicado: (2017) -
Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
por: Shirai, Kumiko, et al.
Publicado: (2022)